WASHINGTON (Reuters) - U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the ...
ROCKVILLE, Maryland (Reuters) - GlaxoSmithKline Plc's widely prescribed drug Advair is safe enough for treating asthma but two lesser-used medicines are too risky, a U.S. advisory panel ruled on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results